Endurant Capital Management’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-45,612
| Closed | -$486K | – | 52 |
|
|
2022
Q4 | $486K | Buy |
+45,612
| New | +$486K | 0.2% | 46 |
|
|
2022
Q1 | – | Sell |
-66,666
| Closed | – | – | 63 |
|
|
2021
Q4 | $0 | Buy |
+66,666
| New | – | ﹤0.01% | 67 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 61 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 62 |
|
|
2020
Q1 | – | Sell |
-22,570
| Closed | -$147K | – | 55 |
|
|
2019
Q4 | $147K | Sell |
22,570
-22,569
| -50% | -$147K | 0.05% | 50 |
|
|
2019
Q3 | $311K | Sell |
45,139
-37,573
| -45% | -$259K | 0.11% | 48 |
|
|
2019
Q2 | $610K | Buy |
+82,712
| New | +$610K | 0.24% | 45 |
|